$80m ATM probably they have been selling today but hardly any dilution considering $ terms. They may do a clean secondary after TRD is out Q1’20 at lot higher price.
AXSM can sell shares at their discretion (whenever they want to). I think they'll wait until the results are announced for the AXS-07 trial for migraines which are scheduled to be announced before the end of the year.
News 
Market Data 
Discover 
